Logo image of CTNM

CONTINEUM THERAPEUTICS INC-A (CTNM) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CTNM - US21217B1008 - Common Stock

11.11 USD
-0.01 (-0.09%)
Last: 12/4/2025, 12:07:20 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CTNM revenue by date.CTNM revenue by date.
50M
-100.00%
13.991M20.137M
43.93%
24.108M
19.72%
98.367M
308.03%
EBITDA
YoY % growth
CTNM ebitda by date.CTNM ebitda by date.
-28.322M-22.391M
20.94%
16.272M
172.67%
-47.375M
-411.18%
-78.747M
-55.52%
-110.365M
-40.15%
-151.161M
-36.97%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
CTNM ebit by date.CTNM ebit by date.
-28.647M-22.72M
20.69%
16.077M
170.76%
-48.276M
-416.56%
-77.658M
-52.59%
-95.227M
-22.62%
-117.995M
-23.91%
-130.632M
-10.71%
-160.887M
-23.16%
-194.171M
-20.69%
-342.086M
-76.18%
-334.417M
2.24%
Operating Margin
CTNM operating margin by date.CTNM operating margin by date.
N/AN/A32.15%N/AN/AN/AN/AN/A-1,149.93%-964.25%-1,418.97%-339.97%
EPS
YoY % growth
CTNM eps by date.CTNM eps by date.
N/AN/AN/A-1.95-2.27
53.66%
-2.62
-15.33%
-2.53
3.28%
-2.59
-2.08%
-2.86
-10.45%
-2.87
-0.63%
-3.65
-27.18%
-3.08
15.63%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.44
20.77%
-0.67
-7.35%
-0.67
-7.76%
-0.55
-21.27%
-0.52
-16.09%
-0.36
46.36%
-0.37
45.04%
-0.31
43.93%
-0.31
40.59%
Revenue
Q2Q % growth
5.1M5.763MN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
-20.723M
-23.43%
-23.062M-24.284M-26.118M
-27.88%
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-14.366M
15.73%
-21.726M
-27.89%
-22.848M
-68.38%
-18.564M
4.72%
N/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.45
-12.50%
-0.490.048.80%
Q2 2025
Q2Q % growth
-0.62
-58.97%
-0.45-0.17-38.15%
Q1 2025
Q2Q % growth
-0.62
82.54%
-0.58-0.04-7.58%
Q4 2024
Q2Q % growth
-0.56 -0.44-0.12-28.28%
Q3 2024
Q2Q % growth
-0.40 -0.420.024.35%
Q2 2024
Q2Q % growth
-0.39 -0.35-0.04-10.03%
Q1 2024
Q2Q % growth
-3.55 -0.47-3.08-656.61%
CTNM Yearly EPS VS EstimatesCTNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 -1 -2 -3 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
7.65M-7.65M-100.00%
CTNM Yearly Revenue VS EstimatesCTNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2029 2030 2031 2032 20M 40M 60M 80M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 10.59% 9.75%
RevenueN/A N/A N/A -100%